Pre-eclampsia (PE) is a hypertensive disorder that occurs during pregnancy, and is a multifactorial disease. The antiangiogenic factor, soluble fms-like tyrosine kinase 1 (sFlt-1), has been reported to be important in the pathogenesis of PE, but the mechanism of its involvement remains unknown. To test the effects of sFlt-1 on pregnancy, we injected pregnant mice with exogenous mouse sFlt-1. After 18 days of gestation, higher blood pressure, proteinuria, and histological differences were observed compared with controls. Mitochondrial swelling inside the trophoblast cells in the placenta of sFlt-1-treated pregnant mice was observed by electron microscopy, which suggested a role of sFlt-1 in oxidative stress in trophoblasts in PE. Furthermore, apoptosis markers were upregulated in sFlt-1-treated mice. In conclusion, sFlt-1 appears to play a role in oxidative stress, which promotes apoptosis of trophoblasts. This may be an important mechanism in the development of PE.
INTRODUCTION
Pre-eclampsia (PE) is characterized by a series of maternal syndromes after 20 wk of gestation, including hypertension and proteinuria. PE affects approximately 3%-8% of first-time pregnancies [1, 2] . PE is thought to be a multifactorial disease that involves oxidative stress, endothelial dysfunction, inflammation, and immunity [3] [4] [5] . Previous studies of PE have shown interactions between inflammation and endothelial dysfunction [6] and between inflammation and oxidative stress [7] . We also previously found a relationship between oxidative stress and immunity in placental trophoblasts in PE [8] . Karumanchi and Bdolah proposed that the relationship between endothelial dysfunction and oxidative stress might be a ''chicken-and-egg'' question [9] . However, the underlying mechanism of endothelial dysfunction and oxidative stress is not well understood.
Soluble fms-like tyrosine kinase 1 (sFlt-1), a potential predictive marker for PE [10] [11] [12] [13] [14] [15] , is known to be an antiangiogenic factor, and is related to endothelial dysfunction [16] [17] [18] . A previous study in rats showed that excessive sFlt-1 resulted in obvious symptoms, including hypertension and proteinuria [19] . Therefore, in the current study, sFlt-1 was used to assess the role of endothelial dysfunction in sFlt-1-treated pregnant mice. We observed mitochondrial swelling inside trophoblast cells under electron microscopy, which suggested the presence of oxidative stress. Therefore, sFlt-1 may play an important role in oxidative stress. We also propose a ''vicious cycle'' between endothelial dysfunction and oxidative stress in the placenta in PE and that this is enhanced by sFlt-1.
In the present study, we found that sFlt-1 has roles in oxidative stress and apoptosis in trophoblasts in a mouse model and in human PE placenta. This may be an important mechanism for the development of PE.
MATERIALS AND METHODS

Patients
PE was defined as new-onset hypertension (140/90 mm Hg for at least two consecutive measurements after 20 wk of gestation) and new-onset proteinuria (300 mg/24 h). Patients with baseline hypertension, proteinuria, or renal disease were excluded from the study. Healthy, normotensive, pregnant women were included as controls and were gestationally matched to the PE patients. Blood samples were obtained from consenting women at the Department of Gynecology and Obstetrics at the People's Hospital of Jiangsu Province, China. Blood was taken on the day the women were admitted to the hospital. Serum was immediately separated for ELISA. Table 1 shows the clinical characteristics of the patients, including maternal age, body mass index, gestational age (at delivery), smoking status, highest systolic and diastolic blood pressure (BP) during the course of the disease, proteinuria, and birth weight. A total of 67 patients were included in the study, and were divided into four groups: 14 preterm PE pregnancies (PP; 29.7-33.7 wk), 17 normal preterm pregnancies (NPP; 33.2-34.1 wk), 18 term PE pregnancies (TP; 37.1-38.5 wk), and 18 normal term pregnancies (NTP; 38.7-39.7 wk). This study was approved by the Ethics Board of the First Affiliated Hospital of Nanjing Medical University.
Mice
Adult ICR mice (26-30 g ) were purchased from the Experimental Animal Center of Nanjing in Jiangsu Province, China. Male and female mice (2:1) were caged together in a temperature-controlled room (238C) with a 12L:12D cycle. The female mice were checked for vaginal plugs each day. If a plug was found, we recorded this as Day 0.5 of gestation (DG 0.5). On DG 9 (early second trimester), mice were injected daily with either recombinant mouse sFlt-1-Fc (12 lg sFlt-1 dissolved in sterile saline; n ¼ 5) or vehicle (sterile saline, n ¼ 5) by intraperitoneal injection for 8 consecutive days (through DG 16, early third trimester). BP was measured in both groups on DG 17 by the tail-cuff method using a programmed electrosphygmomanometer (model BP-98A; Softron). On DG 18, the mice were killed, and blood and urine, as well as placenta, uterus, and kidney tissues, were obtained. Serum was analyzed for sFlt-1 levels by ELISA. Urinary albumin levels were measured using a urinary protein kit (Beyotime). All experimental procedures performed in this study were in accordance with the National Institutes of Health guidelines for the use and care of animals. All protocols were approved by the Institutional Animal Care and Use Committee at Nanjing Medical University.
Reagents
Recombinant mouse sFlt-1-Fc, human sFlt-1, and mouse sFlt-1 ELISA kits were purchased from R&D Systems. Anti-b-actin polyclonal antibody was purchased from Santa Cruz Biotechnology. Monoclonal antibodies (anti-Bcl-2, anti-Bax, anti-cleaved caspase-3, and anti-hypoxia-inducible factor [HIF]-1a) and goat anti-mouse and goat anti-rabbit horseradish peroxidase-conjugated antibodies were purchased from Cell Signaling Technology.
Electron Microscopy
Harvested placentas and kidneys were fixed in glutaraldehyde and embedded in an araldite-epon mixture. Sections of 1 lm in size were cut and JIANG ET AL.
stained with methylene blue. Ultrastructures were assessed by electron microscopy.
Superoxide Dismutase and Malondialdehyde
Superoxide dismutase (SOD) levels in mouse serum were measured using the Total Superoxide Dismutase Assay Kit (Beyotime) according to the manufacturer's instructions. Serum malondialdehyde (MDA) levels were measured using the Lipid Peroxidation MDA Assay Kit (Beyotime), according to the manufacturer's instructions.
ELISA
Human and mouse circulating sFlt-1 in serum levels were measured by human sFlt-1 and mouse sFlt-1 ELISA kits according to the manufacturer's instructions, and these experiment were carried out in duplicate.
TUNEL
A TUNEL kit (Roche) was used to detect apoptotic cells in human and mouse placentas according to the manufacturer's instructions. Fluorescence was assessed with a fluorescence microscope (Nikon Corp.). Nuclei were labeled with 4,6-diamidino-2-phenylindole (Invitrogen, Molecular Probes), and the nick-end was labeled with GFP. Merged images were detected as purple. Positive sections were pretreated with DNaseI solution, and negative sections were pretreated with PBS before addition of the reaction mixture.
Western Blot Analysis
Protein extract preparation from placental samples, as well as those used in Western blot analyses, were performed as described previously [20] . Immunoblotting was performed with antibodies raised against Bcl-2 (1:1000), Bax (1:1000), cleaved caspase-3 (1:1000), HIF-1a (1:1000), and bactin (1:1000). The relative band intensities were analyzed using Syngene tool gel analysis software (Syngene).
Immunohistochemistry
Placentas were fixed in buffered formaldehyde solution (4%) and embedded in paraffin. Serial sections (4 lm thick) were cut and mounted onto Superfrost Plus slides. The following steps were performed as described previously [21] . The sections were incubated for 1 h with anti-HIF-1a (1:100). After incubation, polymer-linked secondary reagent was used, and staining was visualized using 
Statistical analyses
Statistical analyses were performed using SPSS 17.0 software (SPSS Inc.). Paired and unpaired t-tests were used to compare results between two groups, and ANOVA was used to compare data from four groups. Data are presented as means 6 SD. Differences were considered statistically significant at P , 0.05.
RESULTS
Production of sFlt-1 Is Elevated in Patients with PE
The clinical parameters of this study are shown in Table 1 . Comparisons of the parameters were made between patients with matched gestational ages (PP vs. NPP and TP vs. NTP). No significant differences were observed between maternal age (P . 0.05), body mass index (P . 0.05), gestational age (P . 0.05), or smoking status (P . 0.05) between the groups (Table  1) . Proteinuria (P , 0.05) and systolic and diastolic BP measurements (P , 0.05 for both) of both PE groups (PP and TP) were higher than those of the matched normal groups (NPP and NTP). However, the mean birth weight of the normal groups was significantly higher than that of the PE groups. Serum sFlt-1 levels in the PP group were significantly higher than those in the other three groups (all P , 0.01, Table 1 ). Serum sFlt-1 levels in the TP group were significantly higher than those in the two normal groups (NPP, P ¼ 0.012; NTP, P ¼ 0.004).
Effect of sFlt-1 Treatment in Mice
To verify the role of sFlt-1 on PE, we injected pregnant DG 9 mice with exogenous recombinant murine sFlt-1 for 8 consecutive days until BP measurements were taken on DG 17 (Fig. 1A) . The parameters of the mice used in this experiment are shown in Table 2 . The mean sFlt-1 protein level in sFlt-1-treated mice was 2.5 6 0.13 ng/ml, which was significantly higher than that in saline-treated control mice (P , 0.01). Soluble Flt-1-treated mice had significantly higher BP values than the control mice (systolic BP, 160.8 6 3.3 vs. 112.2 6 3.8 mm Hg, P , 0.01; mean arterial pressure, 110 6 3.5 vs. 93 6 2 mm Hg, P ¼ 0.026). The sFlt-1-treated mice developed greater proteinuria than the control group (P , 0.01). There were no differences in diastolic BP or the number or weight of pups between the groups (P . 0.05).
In sFlt-1-treated mice, we observed swelling and greater calcification of the villous vessels and thinner glands of the uterus than in the control mice (Fig. 1B, b and d) . Formation of glomerular vascular branches and slight swelling of glomerular capillary endothelial cells were also observed by hematoxylin and eosin staining in sFlt-1-treated mice (Fig.  1B, f) . Additionally, locally thickened basement membranes of glomerular endothelial cells and fusion of foot processes were observed under electron microscopy in sFlt-1-treated JIANG ET AL. mice (Fig. 1C, b) , suggesting greater proteinuria in those mice. All of these changes in the placenta, uterus, and kidney are similar to the pathological changes that occur in human PE.
Soluble Flt-1 Induces Oxidative Stress in Mouse Placental Trophoblasts
Importantly, in the mouse model, we found that oxidant MDA levels were higher, while antioxidant SOD levels were lower in the serum of sFlt-1-treated mice than in the serum of control mice (Fig. 2A) . Furthermore, swollen mitochondria were observed in trophoblast cells under electron microscopy in the placentas of sFlt-1-treated mice (Fig. 2B, a-d) . This finding suggests an effect of sFlt-1 on oxidative stress. HIF-1a showed extensive positive staining in the placentas of sFlt-1-treated mice (Fig. 3A, b) . Therefore, a vicious cycle may exist in the PE placenta as follows: sFlt-1 causes damage to placental vessels, resulting in hypoxia and oxidative stress in trophoblasts, and further leading to secretion of sFlt-1 (Fig.  3B) .
The Vicious Cycle Aggravates Apoptosis in Trophoblasts
Because apoptosis is an important mechanism in PE, the role of the vicious cycle in apoptosis was assessed. Apoptosis was more extensive in trophoblasts derived from PE placentas than in controls, as shown by TUNEL assay (Fig. 4A) . More apoptotic cells were also observed in the placentas of sFlt-1-treated mice than in control mice (Fig.  4B) . The levels of mitochondrial apoptosis-related proteins, such as Bax, Bcl-2, and cleaved caspase-3, were also analyzed. Apoptotic Bax and cleaved caspase-3 were upregulated and the antiapoptotic protein Bcl-2 was downregulated in sFlt-1-treated mice (Fig. 5A ) and the PE placenta (Fig. 5B) .
DISCUSSION
In recent years, research has focused on the relationship between antiangiogenic factors and PE, and this relationship may predict PE. Krysiak et al. reported that serum sFlt-1 levels are increased in patients with PE [22] . Stepan et al. also found high sFlt-1 levels in most PE patients [23] . In addition, earlyand late-onset PE are associated with elevated plasma sFlt-1 levels [24] , and patients at high risk of developing preterm and term PE have significantly higher plasma concentrations of sFlt-1 at midgestation than control patients [25] . Our study showed that sFlt-1 concentrations in the early-onset PE group were notably higher than those in the late-onset PE group. This finding suggests that sFlt-1 may be a good marker for earlyonset PE. Previous studies have supported the hypothesis that an earlier onset of PE corresponds with higher sFlt-1 levels [26, 27] . However, there are still some discrepancies in the reported sFlt-1 protein levels between studies. In our patient cohort, sFlt-1 concentrations were higher than those reported by Stepan et al., who only found 1.4 ng/ml sFlt-1 in the plasma of women with PE compared with 0.4 ng/ml sFlt-1 in controls during the second trimester [23] . We believe that the difference in the results of these two studies may be due to the gestational week chosen for the measurement of sFlt-1 level. The patients included in our study were at 29.7-33.7 wk of gestation, which is considerably later than the patients at 19-24 wk of gestation in the study by Stepan et al. [23] . Furthermore, the serum samples were not diluted in our study. Nonetheless, our results are consistent with those of previous studies: serum sFlt-1 ROLE OF sFlt-1 IN PREECLAMPSIA protein levels in women with PE were approximately three times higher than in the corresponding controls [23, 28] .
We injected mice with recombinant sFlt-1 to determine the importance of sFlt-1 in the underlying mechanism of PE. Excess sFlt-1 resulted in obvious symptoms, including hypertension and proteinuria. This is consistent with rat models of PE that used sFlt-1 infusion [29, 30] or adenovirus-infection protocols [19] . However, our results only showed a mild decrease in pup birth weight in the sFlt-1-treated group compared with the control group. Bridges et al. reported that fetuses and placentas from sFlt-1-infused rats had lower weights than those from vehicle-infused rats [29] . This difference between studies could be due to the different administration methods that were used. The rats in the study by Bridges et al. received sFlt-1 via a mini-osmotic pump, which may have resulted in a more consistent serum sFlt-1 concentration, and may have provided a longer-lasting stimulus to the pups via the placenta [29] . The mice in our study received sFlt-1 injections once a day for 8 days, which may have resulted in less mental stimulation of the mice, reducing the possible effects of stress on BP. However, our protocol achieved a 2.8-fold increase in sFlt-1 serum concentrations and caused hypertension and proteinuria, suggesting that our experimental intervention was effective.
Although many studies have focused on the role of sFlt-1 in PE, the underlying mechanism still remains unclear. Soluble Flt-1 is considered to be an antiangiogenic factor that acts by antagonizing the role of vascular endothelial growth factor, and it is related to endothelial dysfunction. In the present study, sFlt-1 was also found to play a role in oxidative stress. Soluble Flt-1 seems to be an important linker between oxidative stress and endothelial dysfunction. Karumanchi and Bdolah proposed that the relationship between endothelial dysfunction and oxidative stress might be a ''chicken-and-egg'' question [9] ; however, they did not find the detailed mechanisms of this relationship. A previous study showed that increased oxidative stress resulting from elevated sFlt-1 contributes to vascular dysfunction in the mouse placenta [23] . Therefore, considering our findings, sFlt-1 could be a causal link between endothelial dysfunction and oxidative stress. Additionally, we hypothesize that the following vicious cycle exists in the PE placenta: sFlt-1 induces damage of placental vessels, causing hypoxia and oxidative stress of trophoblasts, which, in turn, results in more secretion of sFlt-1. However, the possibility of this vicious cycle needs further verification by future studies.
An imbalance between the expressions of apoptotic Bax and antiapoptotic Bcl-2 and more extensive DNA damage were observed in sFlt-1-treated mice and the PE human placenta. These findings are consistent with the observation of swollen mitochondria in placental trophoblasts of sFlt-1-treated mice, and all of these findings collectively suggest that the mitochondrial apoptotic pathway is activated by sFlt-1. Previous reports have shown that oxidative stress may have a close relationship with apoptosis in trophoblast cells in PE [31, 32] . Exaggerated placental apoptosis is common in PE and in intrauterine growth-retarded placentas and the expressions of a variety of pro-and antiapoptotic proteins are altered in placentas [33] . We hypothesize that sFlt-1 activates the apoptotic pathway in trophoblasts. Further studies are required to verify this hypothesis.
In the present study, we found that sFlt-1 plays a role in oxidative stress, resulting in activation of apoptosis in JIANG ET AL.
